Skip to main content

Table 1 Demographic and clinical characteristics of patients

From: The predictive value of C-reactive protein to albümin ratio for ascending aort progression in patients with ascending aortic diameter of 40–50 mm

Variable

Ascending Aorta growth ≤ 1.00 mm/year

Ascending Aorta growth > 1.00 mm/year

p value

Age (years)

45.5 ± 5.8

47.6 ± 4.9

0.034

Female gender n (%)

54 (39)

15 (33)

0.466

DM n (%)

9 (7)

3 (7)

0.982

Hypertension n (%)

22 (16)

25 (56)

 < 0.001

Peripheric arterial disease n (%)

2 (2)

2 (4)

0.236

COPD n (%)

3 (2)

4 (9)

0.043

Smoking n (%)

23 (27)

7 (22)

0.567

Previous stroke n (%)

1 (1)

2 (4)

0.090

Positive familial history n (%)

14 (10)

14 (34)

0.001

Previous PCI n (%)

7 (5)

1(2)

0.412

LVEF (%)

53.9 ± 5.0

54.0 ± 4.6

0.980

Type of aortic dilatation patterns

  

0.485

 Aortic root dilatation n (%)

93 (68)

28 (62)

 

 Tubular dilatation n (%)

44 (32)

17 (38)

 
  1. CAD coronary artery disease, DM diabetes mellitus, LVEFleft ventricular ejection fraction, COPD chronic obstructive pulmonary disease, PCI percutaneous coronary intervention